CRISPR Therapeutics (CRSP) PT Raised to $51 at Citi
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $57.02 -4.17%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 58
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 58
Join SI Premium – FREE
Citi raised its price target on CRISPR Therapeutics (NASDAQ: CRSP) to $51.00 (from $20.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MongoDB (MDB) PT Raised to $460 at UBS Ahead of Q2 Results
- Palo Alto Networks (PANW) PT Raised to $400 at Benchmark Ahead of Q4 Earnings
- CoreWeave (CRWV) PT Raised to $165 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
